Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma: an open-label randomised controlled trial
Author:
S Vincent Rajkumar,Susanna Jacobus,Natalie S Callander,Rafael Fonseca,David H Vesole,Michael E Williams,Rafat Abonour,David S Siegel,Michael Katz,Philip R Greipp
Publication:
The Lancet Oncology
Copyright © 2010 Elsevier Ltd. All rights reserved.